Financial Performance & Guidance - Q3 2025 Adjusted EBITDA was $68 million[6], which annualizes to a run rate of $272 million[6] - Q4 2025 Adjusted EBITDA guidance is $65-70 million[13] - Q1 2026 Adjusted EBITDA guidance is $70-75 million[13] - Power Solutions Adjusted EBITDA for Q3 2025 was $58 million[13], with Q4 2025 guidance of $56-60 million[13] - Logistics Solutions Adjusted EBITDA for Q3 2025 was $17 million[13], with Q4 2025 guidance of $18-20 million[13] Capital Expenditures & Debt - Consolidated Capex for Q3 2025 was $63 million[9] - Remaining consolidated capex spend reflects standalone SEI needs as JV has its own third-party financing[9] - Pro Forma Potential Gross Debt with Fully Deployed JV Capacity is approximately $1403 million[6, 15] - Net to SEI Debt with Convertible Notes considered as Debt is approximately $1153 million[6, 15] - Net to SEI Debt with Convertible Notes considered as Shares is approximately $250 million[6, 15] Fleet & Capacity - Pro Forma Adjusted EBITDA at 2200 MW Operated is projected at $575-625 million Net SEI and $700-750 million Consolidated SEI[6] - The company expects to grow to a 2200 MW operated fleet by early 2028[9]

Company Overview - Chicago Atlantic Real Estate Finance is a commercial mortgage REIT and institutional lender focused on state-licensed cannabis operators[10] - The company has closed over $3.2 billion in loans since its platform inception[8, 10] - The company's outstanding loan principal is $399.9 million with a gross portfolio yield of 16.5%[8] - The real estate collateral coverage in the current portfolio is 1.2x[8] Portfolio Diversification - The top 10 loans account for 65.7% of the outstanding loan principal[23] - The portfolio is diversified by rate type, with 36.7% in fixed-rate loans and 63.3% in floating-rate loans[23, 67] - The portfolio is diversified across various states, with Illinois at 19%, Ohio at 16%, Florida at 8%, Michigan at 14%, and California at 7%[26] - Loans with Retail/Industrial collateral are 31.6% and 47.1% of the portfolio respectively[28, 32] Financial Performance - For the three months ended September 30, 2025, net income was $8.93 million, or $0.42 per basic share[68] - Distributable Earnings for the three months ended September 30, 2025, were $10.52 million, or $0.50 per basic share[69]

IMPORTANT DISCLOSURES FORWARD-LOOKING STATEMENTS Certain statements made within this presentation contain forward-looking statements. Forward-looking statements are not guarantees of future performance and by their nature are subject to inherent uncertainties. Actual results may differ materially. Any forward-looking information relayed in this presentation speaks only as of November 4, 2025, and Hertz Global Holdings, Inc. ("Hertz Global" or the "Company") undertakes no obligation to update that informatio ...

Financial Performance Highlights - Net revenues increased by 9.1% (8.0% on a constant currency basis) to $311312000 in Q3 2025 compared to $285468000 in Q3 2024[31] - Adjusted EBITDA increased by 12.2% (11.2% on a constant currency basis) to $164000000 in Q3 2025 compared to $146000000 in Q3 2024[31] - Adjusted EBITDA margin increased by 147 basis points to 52.7% in Q3 2025[25, 31] - Adjusted EPS increased by $0.09 to $0.26 in Q3 2025[25, 31] - Net Leverage Ratio improved to 3.3x as of September 30, 2025, compared to 3.7x as of December 31, 2024[29, 44] Segment Performance - Sterigenics' revenue increased by 9.8% (8.4% on a constant currency basis) in Q3 2025[33] - Nordion's revenue increased by 22.4% (23.6% on a constant currency basis) in Q3 2025[36] - Nelson Labs' revenue decreased by 5.0% (-6.4% on a constant currency basis) in Q3 2025[39] Liquidity and Capital Deployment - Strong liquidity position of $891000000 as of September 30, 2025, with no outstanding borrowings on the revolving line of credit[29, 43] - Executed $75000000 Term Loan repayment in Q3 2025[29] 2025 Outlook - Full-year 2025 net revenue growth is expected to be between 4.5% and 6.0%[52] - Full-year 2025 Adjusted EBITDA growth is expected to be between 6.75% and 7.75%[52]

Q3 2025 Performance Highlights - Thomson Reuters Q3 organic revenue grew by 7%, driven by a 9% increase in recurring revenue[13] - The "Big 3" (Legal, Corporates, and Tax & Accounting) experienced a 9% organic revenue growth[13] - Reported revenues increased by 3% to $1.8 billion[16] - Adjusted EBITDA increased by 10% to $672 million, with a margin of 37.7%, up 240 basis points[14] - Adjusted EPS increased by 6% to $0.85[14] Financial Outlook and Framework Updates - The company reaffirmed its FY 2025 outlook, expecting total and organic revenue to trend towards the lower end of the 3.0%-3.5% and 7.0%-7.5% ranges, respectively, while maintaining the Big 3 organic revenue growth outlook at approximately 9%[13] - For 2026, the company now anticipates adjusted EBITDA margin expansion of approximately 100 basis points and Free Cash Flow of approximately $2.1 billion[13] Capital Allocation and Liquidity - Thomson Reuters completed a $1.0 billion share buyback in October[13] - The company's net leverage stood at 0.6x as of September 30, with an estimated ~$9 billion of capital capacity by 2027[13] Segment Performance - Legal Professionals organic revenue grew by 9%, primarily driven by Westlaw and CoCounsel[13] - Corporates revenue increased by 10% to $0.5 billion[16] - Tax & Accounting Professionals revenue increased by 13% to $0.3 billion[16]

Financial Performance - Net sales reached $220 million, a 13% year-over-year increase[12] - Diluted Non-GAAP EPS was $072, up 22% year-over-year[12] - Adjusted EBITDA margin was 205%, a decrease of 40 bps year-over-year[12] - Gross profit increased 21% year-over-year, with gross margin expanding 200 bps[23] Segment Performance - Hydraulics segment sales were $1413 million, up 9% year-over-year[38] - Electronics segment sales were $790 million, up 21% year-over-year[41] Cash Flow and Debt - Free cash flow was $185 million[43] - Net debt to TTM adjusted EBITDA ratio was 24x[54] Outlook - Full year 2025 total net sales are projected to be between $820 million and $830 million, representing a 2% to 3% increase relative to 2024[56] - Full year 2025 diluted Non-GAAP EPS is projected to be between $243 and $250, representing a 16% to 19% increase relative to 2024[56] - Fourth quarter 2025 sales outlook for Hydraulics is $121 million to $128 million, a 1% to 7% increase versus Q4 2024[59] - Fourth quarter 2025 sales outlook for Electronics is $71 million to $74 million, a 19% to 24% increase versus Q4 2024[59]

ORMAT TECHNOLOGIES, INC. Q3 2025 EARNINGS CALL FINANCIAL PERFORMANCE AND STRATEGIC UPDATES SAFE HARBOR STATEMENT AND NON-GAAP METRICS THIS PRESENTATION INCLUDES FORWARD-LOOKING STATEMENTS, AND THE DISCLAIMER SHOULD BE READ CAREFULLY FORWARD-LOOKING STATEMENTS This presentation, and information provided during any discussion accompanying this presentation, may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve estimates, e ...

Financial Performance - Total Group Revenue reached $557 million, a 26% year-over-year increase[12, 16] - Group Adjusted EBITDA was $152 million, reflecting a 65% year-over-year growth and a 27% margin[12, 16] - Ex-U S Adjusted EBITDA increased by 42% year-over-year to $149 million[16] - The company paid out $20 million in dividends during the quarter, with a last twelve months total of $136 million[14] Customer Engagement - Average Unique Monthly Active Customers reached a new all-time high of 55 million, an 18% year-over-year increase, peaking at approximately 6 million in September[14, 16] Revenue Diversification - Net Revenue by geography shows continued global diversification, with Americas contributing 33%, Africa 41%, Europe 20%, and RoW 6% of the $550 million total in 3Q 2025[22] - Online Casino accounted for 84% of Net Revenue, while Sports contributed 16%[27] Operational Expenses - Direct Expenses accounted for 37% of Total Revenue Ex-U S [63] - Marketing Costs represented 21% of Total Revenue Ex-U S [63] - G&A Expenses accounted for 15% of Total Revenue Ex-U S [63] Guidance - The company updated its 2025 guidance, projecting Total Revenue between $217 billion and $227 billion and Adjusted EBITDA between $555 million and $565 million[75]

Financial Performance - Total revenues reached $61.5 million, a 2.2% year-over-year increase compared to $60.2 million in 3Q'24 [8] - Non-GAAP gross margin was 65.8%, slightly up from 65.6% in 3Q'24 [8] - Non-GAAP operating margin stood at 9.5%, compared to 11.7% in 3Q'24 [8] - Non-GAAP EBITDA margin was 11.2%, down from 13.1% in 3Q'24 [8] - Non-GAAP EPS was $0.17, a slight increase from $0.16 in 3Q'24 [8] - The company's Live ARR increased by approximately 25% year-over-year [10] Business Segment Performance - Customer Experience (CX) business experienced a 13% year-over-year increase [10] - Conversational AI business saw a significant 50% year-over-year increase [10] - Microsoft Teams business decreased by 1.4% year-over-year, but increased 4% for the first nine months of 2025 [10] Additional Financial Data - Non-GAAP net income was $4.882 million for the three months ended September 30, 2025, compared to $5.681 million for the same period in 2024 [27]

Financial Performance (Q3 2025) - Reported net sales increased by 4.6% to $205.6 million compared to $196.6 million in Q3 2024[2,5] - Pro forma net sales (excluding M6 product lines) increased by 6.3% to $203.4 million compared to $191.3 million in Q3 2024[2] - Bone Growth Therapies net sales increased by 5.7% to $61.2 million[2] - Spinal Implants, Biologics and Enabling Technologies net sales increased by 5.6% to $108.6 million[2] - Global Orthopedics net sales increased by 10.1% to $33.6 million[2] - Adjusted EBITDA increased to $25.114 million, representing 12.2% of reported net sales, compared to $19.180 million or 9.8% in Q3 2024[7] - Pro forma adjusted EBITDA increased to $24.582 million, representing 12.1% of pro forma net sales, compared to $17.515 million in Q3 2024[7] Financial Performance (YTD 2025) - Net sales increased to $602.401 million from $583.834 million[5] - Adjusted EBITDA increased to $55.241 million, representing 9.2% of reported net sales, compared to $43.478 million or 7.4% in YTD 2024[7] - Free cash flow improved to -$18.099 million compared to -$24.285 million in YTD 2024[9] Balance Sheet (September 30, 2025) - Cash and cash equivalents totaled $62.860 million, down from $83.238 million at the end of 2024[3] - Total assets amounted to $832.610 million, compared to $893.294 million at the end of 2024[3]